Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Olfactory receptor 51I2 (OR51I2) is a transmembrane protein expressed predominantly in the olfactory epithelium, where it interacts with odorant molecules and initiates neuronal signaling for smell perception[5][4]. It belongs to the large family of G protein-coupled receptors (GPCRs), specifically the class A (rhodopsin-like) subgroup[5][3]. The binding pocket of OR51I2 is adapted to recognize carboxylic acid–containing odorants, leveraging a highly conserved arginine residue that interacts closely with the carboxyl group of the ligand, a feature shared within its subfamily[1][2]. The receptor undergoes a distinct structural rearrangement upon agonist (odorant) binding, leading to activation of G protein signaling pathways (notably involving Gαolf and Gαs)[1][2]. While its primary function is olfactory signaling, emerging evidence suggests extranasal expression and possible involvement in physiological processes beyond smell[3]. Its direct therapeutic targeting is currently unexplored, and no drugs selectively modulating OR51I2 have entered clinical use.
Agonist binding (odorant activation triggers G protein signaling and subsequent cAMP production); Selectivity determined by tight, supportive hydrophobic and ionic interactions between the odorant and receptor binding pocket
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Olfactory receptor 51I2 (OR51I2).